Bioactive Compounds
-
A4690 PemigatinibSummary: An orally selective FGFR inhibitor for the treatment of cholangiocarcinoma -
C6571 Nicotinuric acidSummary: An acyl glycine metabolite and biomarker of niacin in mammals -
C6713 Pazufloxacin mesylateSummary: An antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections -
C6757 CarbendazimSummary: A broad-spectrum benzimidazole fungicide with antitumor activity -
C6997 DFO3 CitationSummary: A fluorescent reagent for revealing latent fingerprints on porous surfaces -
C7027 10-Hydroxydecanoic acidSummary: A fatty acid with anti-inflammatory, immune-enhancing and antigen-specific immune activities -
C7157 Amodiaquine hydrochlorideSummary: A compound with antimalarial activity that inhibits histamine N-methyltransferase and activates Nurr1 -
B8914 Pseudobufarenogin -
A2517 Tetracycline Hydrochloride2 CitationSummary: Bacteriostatic antibiotics -
A7032 TBTUSummary: peptide coupling reagent

